Introduction
Reproduction is an important criterion in economic terms in livestock breeding, as well as in rabbit breeding. In our work we have tried to improve the reproductive parameters in rabbits. Based on these requirements, we chose two substances that have been tested in rabbit reproduction previously (IBMX, dbcAMP) and a hormone (OT) which was not previously tested together with gonadotropin administration.
The involvement of cyclic nucleotides (cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP)) and their targets (protein kinases A (PKA) and G (PKG)) in the control of reproductive processes is well documented. Both cAMP [1] [2] [3] [4] [5] and cGMP [6, 7] play an important role in the control of ovarian cell proliferation, apoptosis, secretory activity, and oocyte maturation and in mediating the effect of hormonal stimulators on these processes. cAMP can mediate the effect of some hormones on oviduct functions too [8] [9] [10] . Both cyclic nucleotides are hydrolyzed by the enzymes known as phosphodiesterases (PDEs) . Concerning the role of PDEs in control of mice reproduction, the available reports are contradictory. From one side, mice deficient in cAMP-specific phosphodiesterases -PDE3A and PDE4 -have impaired differentiation of ovarian cells, response to gonadotropin, oocyte maturation, ovulation and fertility [2, 11, 12] . On the other hand, synthetic PDE4 inhibitors increased cAMP accumulation in ovarian cells, as well as the number of ovulations, embryos and born pups in gonadotropin-stimulated rats [13] . Therefore, the involvement of PDEs in control of animal reproduction remains to be validated by further studies. Previous experiments performed on rabbits demonstrated the influence of IBMX, an inhibitor of cAMP-and cGMP-specific PDEs, on ovarian folliculogenesis, atresia, and steroid hormone release, as well as proliferation and apoptosis of ovarian and oviductal cells [14] . These findings suggest that PDEs and their targets -cyclic nucleotides and PKA or PKG -could be potent regulators of reproductive processes in laboratory rodents and farm animals.
dbcAMP is a synthetic analogue of cAMP and stimulator of cAMP-dependent protein kinase A. Analogues of cAMP can decrease in porcine granulosa cells [15] and increase in rat granulosa cells [16, 17] the expression of FSH receptors and its mRNA, whilst PDE inhibitor can reduce expression of LH receptors in rat ovary [18] . dbcAMP stimulated ovarian progesterone production, but did not affect ovulation or maturation of follicular oocytes in ovaries perfused in vitro [19] . The addition of dbcAMP to culture medium promoted accumulation of both proliferation and apoptosis markers in cultured ovarian fragments [20] . The data of Sirotkin et al. [20] demonstrate that IBMX and dbcAMP can enhance the stimulatory effect of gonadotropins (FSH, LH) on rabbit ovarian and oviductal functions and on rabbit fecundity via changes in ovarian hormone (progesterone, estradiol) release, ovarian and oviductal cell proliferation and apoptosis. Moreover, it is not to be excluded that PKA activators (PDE inhibitors or cAMP analogues) could be stimulators of reproduction in animal breeding and in human and veterinary medicine. Therefore, further examination, confirmation and comparison of IBMX and dbcAMP's effects on reproduction are required from both theoretical and practical viewpoints.
OT is not considered the most important reproductive hormone, but the following data suggest that it plays an important role in reproductive processes. In our study we wanted to verify our hypotheses that intramuscular administration of exogenous OT can have similar effects as endogenous OT and that it is able to affect reproductive parameters in rabbits. Nonapeptide hormones (OT, vasopressin and their analogues) are important autocrine, paracrine and endocrine regulators of ovarian secretory functions [21] . In the ovary cells of pigs, cattle, rabbits, mice and humans OT regulates the secretion of progesterone, estradiol, IGF-I (insulin-like growth factor I), prolactin-like substances, prostaglandin F2α, cAMP and cGMP and ovarian autocrine mechanism that regulates folliculogenesis and luteogenesis [22, 23] . In addition, ovarian OT plays a role in the ovulatory process through the formation of PGF2 alpha, which strengthens the contraction of smooth ovarian muscle [23, 24] . OT was shown to promote ovarian cell proliferation [23] , suggesting their potential stimulatory action on ovarian follicular growth and development. Besides the hypothalamus, OT and probably other nonapeptide hormones are produced by follicular granulosa cells, especially after their luteinisation under the influence of gonadotropins, IGF-I and other hormonal stimulators. The majority of OT presented in ruminant blood is of ovarian origin. In addition, OT could be produced by the placenta and some other tissues [25] . Receptors for OT are present in ovarian follicles, corpus luteum, oviduct, uterus and other reproductive organs [26] . OT is able to stimulate follicular growth in vitro, granulose cell proliferation and release of progestagen, androgen, estrogen, IGF-I, inhibin A, prostaglandins F and E, cAMP and cGMP (but not IGFBP-3), whilst immunoneutralisation of OT inhibited secretory activity of ovarian cells [27] . During corpus luteum development, OT promotes proliferation and luteinisation/progesterone release by luteal cells [28] [29] [30] . Not only can OT promote cAMP production, but the effects of OT can also be mediated by cAMP/protein kinase A-dependent intracellular mechanisms [23] . Therefore, it is possible that OT, like pharmacological activators of protein kinase A, can be used for stimulation of reproductive processes. Nevertheless, the data concerning the effect of cAMP/ protein kinase A-dependent mechanism activators on reproductive efficiency are insufficient, whilst the effect of OT on fecundity has not been studied yet.
The aim of our study was to examine the influence of IBMX, dbcAMP and OT administration on reproductive efficiency and fertility in female rabbits whose ovarian cycle and ovulation were induced by gonadotropins.
Experimental Procedures

Manipulations with animals
New Zealand White (NZW) rabbit females, 3.5-4.5 month of age, were bred in individual cages at the local rabbit farm of Animal Production Research Centre Nitra.
First experiment:
Female rabbits in the control group were treated 3 days before artificial insemination (AI) with eCG (Werfaser, Alvetra und Werfft AG, Vienna, Austria, at dose 35 IU/doe) followed after 72 hours by hCG (Werfachor, Alvetra und Werfft AG, Vienna, Austria at dose 80 IU/doe). Gonadotropins were dissolved in phosphate-buffered solution (PBS). Control animals were intramuscularly injected in the hind leg only with these gonadotropins (in 0.5 ml saline per doe), whilst experimental females received gonadotropins with either IBMX (Sigma, St. Louis, MI, USA, 50 µg/doe in 0.5 ml PBS), dbcAMP (Fluka, Heidelberg, Germany, 50 µg/doe in 0.5 ml PBS) or OT (Sigma, St. Louis, MI, USA, 50 µg/doe in 0.5 ml PBS). The concentrations of tested substances were chosen on the basis of previous experiments [31, 32] and the dose of 50 µg appeared to be optimal for our experiment. Immediately before administration of hCG, females were artificial inseminated by freshly diluted sperm (0.5 ml/female). Semen samples from 10 NZW males were collected using an artificial vagina and were used to create a heterospermic ejaculate dose. This ejaculate was routinely diluted in a commercial insemination diluent (MiniTüb, Tiefenbach, Germany) at the ratio of 1:6. Concentration of spermatozoa was 50x10 6 /1 ml ejaculate. In the first experiment, all the animals were kept until parturition, when the conception (pregnancy) rate, parturition rate and number of stillborn pups were recorded. Conception rate is defined as the ratio of pregnant females to the total number of inseminated females x100. Parturition rate is defined as the ratio of females after parturition to the total number of inseminated females x100. The values are expressed as a percentage. We investigated the conception rate on the 17 th day after AI using the abdomen palpation method. Immediately after birth the number of stillborn pups was recorded. On the 40 th day after parturition the number of weaned pups was recorded.
Second experiment:
In the second experiment the females' treatment was the same as in the first experiment, with the difference that we used a superovulatory dose of gonadotropins (eCG 80 IU/doe, hCG 150 IU/doe) to maximize embryo yield. The females were euthanized 19-20 hours after AI and ovulation. We used electrical stunning (Relco, Gewiss, Italy, alternating current 0.3 A/female, frequency 50 Hz, exposition 4 s) and subsequent bleeding. The ovaries and oviducts were collected. We counted the number of corpora lutea in the ovaries immediately after ovary collection. In the ovaries we observed some hemorrhagic follicles, which often occur after superovulatory treatment and are not ovulated. The pronuclear-stage eggs were flushed from the oviducts with PBS and washed in CIM medium + 10% FBS (Fetal bovine serum, Gibco BRL/Invitrogen Corp., Carlsbad, CA, USA). The eggs were cultured in k-DMEM (knock out dulbecco modified eagle´s medium) + 10% FBS at 5% CO 2 39°C up to the blastocyst cell stage. Stages of embryogenesis were determined at different time points of culture under a stereomicroscope at 40-or 100-fold magnification.
The zygotes were counted immediately after the eggs' release from the oviduct (19-20 hours after AI). The zygotes were determined on the basis of morphological criteria (presence of pronuclei, polar bodies, intact zona pellucida and compacted cytoplasm). The embryos at morula stage were counted 72 hours after AI (beginning of blastocoel cavity formation, beginning of trophoblast and embryoblast cell differentiation, compact zona pellucida). The embryos at blastocyst stage were counted 96 hours after AI on the basis of morphological criteria (clear differentiation of the outer layer of trophoblast from the more compact inner cell mass, also known as embryonic stem cells (ESC), increase in the outer diameter of the embryo, narrowing of the zona pellucida). The numbers of corpora lutea, zygotes and embryos at morula and blastocyst stage were referred as total number (n) per female rabbit.
The treatment of the animals was approved by the Ministry of Agriculture and Rural Development of the Slovak Republic, no. SK P 28004 and Ro 1488/06-221/3a.
Statistics
The first experiment was performed on 38 control animals, 41 experimental animals in the IBMX group, 35 experimental animals in the dbcAMP group and 32 animals in the OT group. The second experiment was performed on 10 control animals, 8 experimental animals in the IBMX group, 9 experimental animals in the dbcAMP group and 9 animals in the OT group. Differences in the stillborn and weaned pup categories were evaluated by one-way ANOVA in SigmaPlot 11 (Systat Software Inc., Germany).
Results are expressed as means ± SEM (n±SEM).
A chi-square (χ 2 ) test was used for the evaluation of conception rate and parturition rate. Results are expressed as percentages. A chi-square (χ 2 ) test was used for the evaluation of morphological categorization (number of corpora lutea, zygotes, morula and blastocyst) too. Results are expressed as means ± SEM (n± SEM). Differences at P≤0.05 were considered significant.
Results and Discussion
First experiment
This experiment showed that dbcAMP and OT significantly decreased female fertility parameters -conception rate and parturition rate -compared to the control. Conception rate was 63.9% in the dbcAMP group and 56.3% in the OT group versus 86.8% in the control group. IBMX did not affect this parameter ( Figure 1A) . Parturition rate was 60.0% in the dbcAMP group and 53.2% in the OT group versus 76.3% in the control group. dbcAMP did not positively influence conception and parturition rate, although the ability of dbcAMP to affect production of rabbit steroids, IGF-I and proliferation-related substances suggests that dbcAMP can effect ovarian steroidogenesis and cell proliferation [32] . Addition of IBMX decreased this parameter too, but the data were not statistically significant ( Figure 1B ). Our observations do not confirm the previous data of Sirotkin et al. [31] , who demonstrated that administration of IBMX at doses of 500 μg/female or 50 μg/female to nulliparous young animals (4.5 month of age) significantly increased their pregnancy and birth rate, litter size and litter weight. In our case we found a neutral effect of IBMX on the percentage of pregnant females. In the parameter "stillborn pups", the IBMX group resulted in an average of n=0.5±0.3 stillborn pups/ doe, OT group in an average of n=0.5±0.4 stillborn pups/ doe versus n=1.6±0.6 stillborn pups/doe in the control group, and this difference was statistically significant. We can conclude that the mortality of newborn pups in IBMX and OT groups was reduced. dbcAMP did not affect this parameter ( Figure 1C ). In the parameter "weaned pups", the IBMX group resulted in an average of n=5.9±0.5 weaned pups/doe, dbcAMP group in an average of n=6.2±0.5 weaned pups/doe and the OT group in an average n=6.5±0.5 versus n=3.6±0.6 weaned pups/ doe in the control group ( Figure 1D ). These differences were statistically significant. In this category we observed a positive impact of all three tested substances. These results show that our tested substances could improve offspring viability after birth. In the category "weaned pups", there is a possible outside influence of the rearing environment, so the positive results cannot be clearly attributed to the tested substances. Figure 2 ).
Second experiment
The differences between IBMX, dbcAMP and control group were statistically significant. These results are in accordance with the results of the previous study of Sirotkin et al. [14, 31, 33] , where IBMX injections at doses of 5, 25 or 50 μg/doe significantly increased the number of ovulations/corpora lutea, harvested zygotes and embryos derived from these zygotes. These data confirm the previous report of McKenna et al. [13] that PDE inhibitors can increase the number of ovulations, embryos and born pups in gonadotropin-stimulated rats. Our results do not correspond to the report of Hosoi et al. [19] , where dbcAMP did not affect ovulation or maturation of follicular oocytes in ovaries perfused in vitro. The stimulation of ovaries by exogenous gonadotropins can increase ovulation rate and number of ovulated oocytes, but decrease quality and developmental potential of harvested oocytes [34, 35] .
In our experiments, administration of dbcAMP was able to increase not only the number of harvested oocytes, but also the number of fertilized oocytes (zygotes) and subsequent embryos reaching the morula and hatching blastocyst stages after culture. Furthermore, our results showed that dbcAMP is a more potent regulator of reproductive functions than IBMX. This could be due to the fact that IBMX is a nonspecific inhibitor of cAMP and cGMP phosphodiesterases, whilst dbcAMP specifically targets PKA. These observations confirm the involvement of the cAMP/protein kinase A-dependent intracellular signaling pathway in the control of rabbit reproduction.
OT did not affect the number of corpora lutea, zygotes or embryos at the morula and hatching blastocyst stages in comparison with the control group (Figure 2) . This, probably first, examination did not demonstrate a positive effect of OT on rabbit reproductive efficiency. Since a positive effect of OT on ovarian cell proliferation and ovarian hormone release has been well documented (see Introduction), it is not to be excluded that further studies could show an effect of OT on reproductive efficiency. However, it is possible that the effect of OT on reproductive parameters depends on its origin (endogenous or exogenous) and/or on its site of action (intraovarian or administered intramuscularly). Therefore, further examination of OT's effect on fecundity is required.
There are some differences between the effects of IBMX and dbcAMP observed in our first and second experiments, but they cannot be compared, because there were different experimental models. Further studies are required to confirm a pattern of action of these substances on rabbit female fertility and to understand the variability in these effects. Nevertheless, our preliminary data suggest potential usefulness of both dbcAMP and IBMX for improvement of animal reproductive efficiency. Based on our results, we recommend the use of IBMX and dbcAMP in the rabbit industry. These substances could recruit more embryos from genetically precious animals, and these embryos can be used for genetic micromanipulation or frozen in an embryo bank.
